Market Report, "Oxford Biodynamics Limited - Product Pipeline Analysis, 2013 Update", Published
Oxford Biodynamics Limited (Oxford Bio) is a biotechnology company. The company develops biomarker discovery platform. Its products under clinical development include OBD 27, OBD 29, OBD 35, OBD 73, OBD 26, OBD 85, OBD 87 and OBD. Oxford Bio's products are used in the areas of breast cancer diagnostics, prostate cancer progression, melanoma diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, neurodegenerative disease diagnostics, and age related disease diagnostics. The company's EpiSwitch biomarker platform is based on mechanisms of gene expression,...
View full press release